Dyadic International (DYAI) Short-term Investments (2017 - 2026)
Dyadic International's (DYAI) quarterly Short-term Investments came in at $1.4 million in Q1 2026, down 40.42% year-over-year from $2.3 million in Q1 2025, and down 49.57% quarter-over-quarter from $2.7 million in Q4 2025.
Analysis
Dyadic International (DYAI) Short-term Investments (2017 - 2026) Analysis & Trends
Dyadic International has disclosed Short-term Investments across 10 years of filings, most recently posting $1.4 million for Q1 2026.
- In Q1 2026, Short-term Investments fell 40.42% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 40.42% YoY), while the FY2025 annual figure was $2.7 million, down 2.1% from the prior year.
- Short-term Investments came in at $1.4 million for Q1 2026 at Dyadic International, down from $2.7 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $3.0 billion in Q1 2022 to a low of $748290.0 in Q4 2023.
- Average Short-term Investments over 5 years is $181.2 million, with a median of $4.0 million recorded in 2024.
- Year-over-year, Short-term Investments jumped 21208.95% in 2022 and tumbled 99.82% in 2023.
- Over 5 years, Short-term Investments stood at $6.8 million in 2022, then sank by 89.07% to $748290.0 in 2023, then jumped by 268.38% to $2.8 million in 2024, then decreased by 2.1% to $2.7 million in 2025, then tumbled by 49.57% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Short-term Investments figures were $1.4 million in Q1 2026, $2.7 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Dyadic International | 17.78 Mn | 9.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.36 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 6.90 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 748,290.00 |
| Sep 30, 2023 | 772,804.00 |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 6.85 Mn |
| Sep 30, 2022 | 7.46 Mn |
| Jun 30, 2022 | 6.16 Mn |
| Mar 31, 2022 | 3.02 Bn |
| Dec 31, 2021 | 4.51 Mn |
| Sep 30, 2021 | 9.09 Mn |
| Jun 30, 2021 | 11.58 Mn |